Cancer Res (2023) 83 (7_Supplement): 1142.
Background: KRAS is a key mediator of the RAS/MAPK signaling cascade and promotes cellular growth and proliferation. It is the most frequently mutated oncogene in cancer, and KRAS G12C mutations occur ...
Cancer Res (2025) 85 (8_Supplement_1): 1160.
Cancer Res (2026) 86 (5_Supplement_2): A010.
Mol Cancer Ther (2023) 22 (12_Supplement): A085.
Cancer Res (2024) 84 (3_Supplement_2): PR014.
Introduction: EBV-associated nasopharyngeal carcinoma (NPC) is a distinct type of head and neck cancer that is prevalence in southern China and Southeast Asia. While radiotherapy or concurrent ...
Abstract. A key barrier to effective immunotherapy for cancer is the immunosuppressive tumor microenvironment (TME) characterized by infiltrating regulatory T cells (Tregs) and myeloid-derived ...
Abstract. This study investigates Nras-mediated Ras-Mapk in epithelial-mesenchymal transition and the therapeutic potential of RAS-MAPK inhibitors in Claudin-low(CL) triple-negative breast cancer ...
1Molecular Pharmacology of Malignant Diseases, Graduate School of Pharmaceutical Sciences, ...
1Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, ...
AbstractPurpose:. Accurate assessment of invasiveness in pediatric thyroid carcinomas is essential to prevent unnecessary surgery and avoid surgery-associated complications. DNA methylation, a proven ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results